Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company is focused on the development of selective versions of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL-2 with superior...
CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program is designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
(0)
•••
HarryGluten
X
View Profile
View Bullboard History
Post by
HarryGluten
on Oct 05, 2021 8:46am
December catalyst two months away!
Not crappin on $nktr, $nltx thor and other il2 players. cancer immuno mkt is huge, there'll be many winners in space not just one. $mdna at $160 mm mkt is the cheapest il2 player with the greatest
...more
(0)
•••
HarryGluten
X
View Profile
View Bullboard History
Post by
HarryGluten
on Oct 04, 2021 10:16am
mdna too cheap / december topline phase 1 results coming
$mdna We know how $nktr and thor did in their ph1-2 trials. They both showed NO monotheraphy efficacy. That's why they are in phase 3 combo trials with checkpoint inhibitors.
...more
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(0)
•••
HarryGluten
X
View Profile
View Bullboard History
Post by
HarryGluten
on Oct 01, 2021 9:35am
October is upon us!
$mdna October is upon us! We are about two months away from mdna reporting preliminary topline results for potential blockbuster mdna 11. Expect a steady run-up to December, and when mdna shows it'
...more
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 30, 2021 12:25am
RE:Clinical Data from Phase 2B Trial
Well it's been almost 2 months and no one else seems to post so I will talk to myself. This thing fell like a rock today. It was so out of character that it prompted me to send IR an email and ask
...more
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Post by
Pandora
on May 07, 2021 12:32pm
Clinical Data from Phase 2B Trial
T.MDNA | 3 hours ago -- Data published in Clinical Cancer Research indicate that early determination of PFS with modified RANO criteria may be a strong surrogate for overall survival in recurrent
...more
(1529)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on May 05, 2021 12:00pm
RE:Breaking down badly
May of 2020 was a good month for MDNA. The share price ran up to the 52 week high of $7.25 by the end of May. Since then it has been primarily a $5 to $5.50 stock price and over the past month has
...more
(1)
•••
Llofty60
X
View Profile
View Bullboard History
Comment by
Llofty60
on Mar 06, 2021 9:27pm
RE:Breaking down badly
There is no risk. When a company applies for an IND in the US, the FDA may have comments or questions about the structure of the trial. If no comments or concerns then the trial will start within a
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Feb 17, 2021 2:53pm
RE:RE:RE:MDNA short stock thesis for me
Crazywrongboyw , you said that the company was dumping shares but the stock is up 5%. Who are they dumping to? I cant believe that you would lie to us! I am hurt thinking that you tried to mislead us.
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Post by
Sunvalley
on Feb 17, 2021 12:11pm
Bought more yesterday
I had a feeling that news was imminent and I was right. Just got in under the wire as stock is up 4% - 5% today. Another presentation on Feb 26th to spread the word about MDNA,s success in killing
...more
(0)
•••
Crazyrightboyw
X
View Profile
View Bullboard History
Comment by
Crazyrightboyw
on Feb 16, 2021 8:02am
RE:RE:MDNA short stock thesis for me
be an ostrich with head in sand all you want. Doesn't change the fact that company is dumping shares
(0)
•••
Crazyrightboyw
X
View Profile
View Bullboard History
Comment by
Crazyrightboyw
on Feb 16, 2021 8:02am
RE:RE:MDNA short stock thesis for me
</super shocked how much $mdna is selling shares via open market sale facility! alot more than i ever expected. 20% of volume is company selling shares. it will take additional 70 trading days.. 3
...more
(0)
•••
Crazyrightboyw
X
View Profile
View Bullboard History
Post by
Crazyrightboyw
on Feb 16, 2021 8:01am
Crazy stock sales by mdna
Super shocked how much $mdna is selling shares via open market sale facility! Alot more than I ever expected. 20% of volume is company selling shares. It will take additional 70 trading days.. 3
...more
(210)
•••
Sunvalley
X
View Profile
View Bullboard History
Comment by
Sunvalley
on Feb 03, 2021 8:45am
RE:MDNA short stock thesis for me
Are you out of your mind? Did you ever hear of getting set up for expansion purposes ? Clearly you do not what you are talking about. I guess that a possible new gold standard for treating brain
...more
(34)
•••
peterklein
X
View Profile
View Bullboard History
Post by
peterklein
on Feb 03, 2021 6:54am
MDNA short stock thesis for me
$MDNA serious question, why is the company have a huge $25 million open market stock sale facility in place, and are probably selling into this weakness. Question is why??? Seems sketchy no? Will all
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract